Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals (AERI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 928,956
  • Shares Outstanding, K 46,917
  • Annual Sales, $ 83,140 K
  • Annual Income, $ -183,100 K
  • 60-Month Beta 0.58
  • Price/Sales 10.82
  • Price/Cash Flow N/A
  • Price/Book 14.33
Trade AERI with:

Options Overview

Details
  • Implied Volatility 64.03%
  • Historical Volatility 67.16%
  • IV Percentile 5%
  • IV Rank 8.97%
  • IV High 376.69% on 09/14/20
  • IV Low 46.37% on 11/24/20
  • Put/Call Vol Ratio 0.09
  • Today's Volume 136
  • Volume Avg (30-Day) 183
  • Put/Call OI Ratio 0.15
  • Today's Open Interest 1,062
  • Open Int (30-Day) 838

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.65
  • Number of Estimates 3
  • High Estimate -0.63
  • Low Estimate -0.67
  • Prior Year -0.84
  • Growth Rate Est. (year over year) +22.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.16 +30.54%
on 02/22/21
20.35 -2.75%
on 03/01/21
+2.93 (+17.38%)
since 02/03/21
3-Month
11.82 +67.43%
on 12/10/20
20.35 -2.75%
on 03/01/21
+7.14 (+56.44%)
since 12/03/20
52-Week
9.01 +119.64%
on 10/21/20
20.35 -2.75%
on 03/01/21
+2.78 (+16.34%)
since 03/03/20

Most Recent Stories

More News
Aerie (AERI) Rises Despite Q4 Earnings Miss, Revenues Top Mark

Aerie (AERI) up more than 16% despite reporting a wider-than-expected loss in the fourth quarter of 2020. Revenues beat estimates.

PFE : 33.78 (+0.81%)
CANF : 1.99 (-1.00%)
AERI : 20.38 (+2.93%)
OPHLF : 29.7000 (unch)
Aerie Pharmaceuticals (AERI) Reports Q4 Loss, Tops Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of -5.33% and 13.49%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

AERI : 20.38 (+2.93%)
Aerie: 4Q Earnings Snapshot

NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Thursday reported a loss of $46.1 million in its fourth quarter.

AERI : 20.38 (+2.93%)
Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

--Fourth Quarter Net Revenues of $24.7 Million or $80 Per Bottle

AERI : 20.38 (+2.93%)
Aerie Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25,...

AERI : 20.38 (+2.93%)
Aerie Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 20.38 (+2.93%)
Aerie Pharmaceut Has Returned 37.6% Since SmarTrend Recommendation (AERI)

SmarTrend identified an Uptrend for Aerie Pharmaceut (NASDAQ:AERI) on November 9th, 2020 at $11.84. In approximately 3 months, Aerie Pharmaceut has returned 37.64% as of today's recent price of $16.29....

AERI : 20.38 (+2.93%)
Aerie Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on Thursday, February 25, 2021

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 20.38 (+2.93%)
Nystagmus Market 2023: Size, Share, Growth, Trends, Demand, Industry Analysis, Regional Outlook

AERI : 20.38 (+2.93%)
AGN : 193.02 (+0.02%)
BAYRY : 15.6200 (-1.26%)
BMY : 60.61 (-1.08%)
NVS : 87.74 (-0.49%)
PFE : 33.78 (+0.81%)
REGN : 457.50 (+0.58%)
SNPHF : 14.1000 (+3.68%)
VRX.TO : 30.80 (-3.33%)
41.1% Return Seen to Date on SmarTrend Aerie Pharmaceut Call (AERI)

SmarTrend identified an Uptrend for Aerie Pharmaceut (NASDAQ:AERI) on November 9th, 2020 at $11.84. In approximately 3 months, Aerie Pharmaceut has returned 41.11% as of today's recent price of $16.70....

AERI : 20.38 (+2.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are...

See More

Key Turning Points

3rd Resistance Point 21.70
2nd Resistance Point 20.78
1st Resistance Point 20.29
Last Price 20.38
1st Support Level 18.88
2nd Support Level 17.96
3rd Support Level 17.47

See More

Last Price 20.38
52-Week High 20.35
Fibonacci 61.8% 16.02
Fibonacci 50% 14.68
Fibonacci 38.2% 13.34
52-Week Low 9.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar